China Cord Blood Receives $512 Million Take-Private Offer

China Cord Blood Corp., which claims to be China's largest provider of cord banking services, has received a take-private offer of $6.40 per share from Golden Meditech Holdings, the company's largest shareholder. Apparently, the offer was heavily anticipated because the shares closed much higher -- $7.22 -- on Friday. On March 19, when Jayhawk Capital issued an open letter asking China Cord Blood's board to do something about the company's stock price, China Cord Blood was trading for $5.54. More details.... Stock Symbols: (NYSE: CO) (HK: 801) Share this with colleagues: // //